112 related articles for article (PubMed ID: 15007271)
1. Results of treatment of primary liver cancer at Kaunas University of Medicine Hospital.
Jievaltas M; Stoskuviene L; Petrenkiene V; Barauskas G; Pundzius J
Medicina (Kaunas); 2004; 40(2):127-34. PubMed ID: 15007271
[TBL] [Abstract][Full Text] [Related]
2. Preoperative portal vein embolization for liver malignancies.
Tarazov PG; Granov DA; Sergeev VI; Polikarpov AA; Polysalov VN; Rozengauz EV
Hepatogastroenterology; 2006; 53(70):566-70. PubMed ID: 16995463
[TBL] [Abstract][Full Text] [Related]
3. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of the inferior right hepatic vein preserving liver resection.
Takahashi M; Hasegawa K; Aoki T; Seyama Y; Makuuchi M; Kokudo N
Dig Surg; 2014; 31(4-5):377-83. PubMed ID: 25548032
[TBL] [Abstract][Full Text] [Related]
8. [The possibilities of surgical treatment of hepatocellular cancer in patients with liver cirrhosis].
Patiutko IuI; Chuchuev ES; Podluzhnyĭ DV; Agafonova MG
Khirurgiia (Mosk); 2011; (10):13-9. PubMed ID: 22334898
[TBL] [Abstract][Full Text] [Related]
9. Hepatic resection for combined hepatocellular and cholangiocarcinoma.
Liu CL; Fan ST; Lo CM; Ng IO; Lam CM; Poon RT; Wong J
Arch Surg; 2003 Jan; 138(1):86-90. PubMed ID: 12511158
[TBL] [Abstract][Full Text] [Related]
10. [Effect of liver cirrhosis on percutaneous selective portal vein embolization for primary liver cancer].
Sun JH; Zhang YL; Nie CH; Li J; Zhou TY; Zhou GH; Chen LM; He JD; Wu J; Shen Y; Zhang M; Wang WL; Zheng SS
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3831-4. PubMed ID: 24548443
[TBL] [Abstract][Full Text] [Related]
11. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.
Nagino M; Nimura Y; Nishio H; Ebata T; Igami T; Matsushita M; Nishikimi N; Kamei Y
Ann Surg; 2010 Jul; 252(1):115-23. PubMed ID: 20531001
[TBL] [Abstract][Full Text] [Related]
12. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
[TBL] [Abstract][Full Text] [Related]
13. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.
Castells A; Bruix J; Bru C; Fuster J; Vilana R; Navasa M; Ayuso C; Boix L; Visa J; Rodés J
Hepatology; 1993 Nov; 18(5):1121-6. PubMed ID: 8225217
[TBL] [Abstract][Full Text] [Related]
14. [Long-term prognosis after hepatic resection for huge primary liver cancer].
Yuan YF; Li BK; Li JQ; Zhang YQ; Guo RP; Lin XJ; Li GH
Ai Zheng; 2004 Jul; 23(7):821-4. PubMed ID: 15248920
[TBL] [Abstract][Full Text] [Related]
15. Management of spontaneous bleeding due to hepatocellular carcinoma.
Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
[TBL] [Abstract][Full Text] [Related]
16. Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma.
Zhou YM; Sui CJ; Zhang XF; Li B; Yang JM
BMC Gastroenterol; 2017 Feb; 17(1):25. PubMed ID: 28183290
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognosis after arterio-portal embolization for hepatocellular carcinoma.
Mamada Y; Tajiri T; Akimaru K; Yoshida H; Taniai N
Hepatogastroenterology; 2004; 51(55):234-6. PubMed ID: 15011871
[TBL] [Abstract][Full Text] [Related]
18. Caudate hepatectomy for cancer: a single institution experience with 150 patients.
Hawkins WG; DeMatteo RP; Cohen MS; Jarnagin WR; Fong Y; D'Angelica M; Gonen M; Blumgart LH
J Am Coll Surg; 2005 Mar; 200(3):345-52. PubMed ID: 15737844
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization.
Mailey B; Truong C; Artinyan A; Khalili J; Sanchez-Luege N; Denitz J; Marx H; Wagman LD; Kim J
J Surg Oncol; 2009 Sep; 100(3):184-90. PubMed ID: 19572328
[TBL] [Abstract][Full Text] [Related]
20. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis.
Denys A; Lacombe C; Schneider F; Madoff DC; Doenz F; Qanadli SD; Halkic N; Sauvanet A; Vilgrain V; Schnyder P
J Vasc Interv Radiol; 2005 Dec; 16(12):1667-74. PubMed ID: 16371534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
